Monoamine oxidase in health and disease.
D000814:Aniline Compounds; D000818:Animals; D001593:Benzyl Compounds; D001921:Brain / Q000201:enzymology; D002395:Catecholamines; D003863:Depression / Q000188:drug therapy; D006801:Humans; D008928:Mitochondria / Q000201:enzymology; D008995:Monoamine Oxidase / Q000032:analysis / Q000302:isolation & purification; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D009411:Nerve Endings / Q000378:metabolism; D009474:Neurons / Q000201:enzymology; D009638:Norepinephrine / Q000378:metabolism; D010627:Phenethylamines; D013564:Sympathetic Nervous System / Q000378:metabolism; D014363:Tryptamines
D000814:Aniline Compounds; D001593:Benzyl Compounds; D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D010627:Phenethylamines; D014363:Tryptamines; D008995:Monoamine Oxidase; D009638:Norepinephrine